Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has granted fast track designation for the development of TRACON’s (NASDAQ:TCON) lead asset envafolimab (KN035) for patients with locally advanced, unresectable or metastatic undifferentiated pleomorphic sarcoma (UPS) and myxofibrosarcoma (MFS) who have progressed on one or two prior lines of chemotherapy. TRACON shares…

Benzinga

The Worst Biotech Stock to Own in September

Biotech stock Ginkgo Bioworks (DNA) has fallen more than 60% year-to-date. The company has been making some acquisitions recently to aid its growth over the next few years. However, given its weak financials and unfavorable analyst estimates, it may not be wise to invest in this stock now. Continue reading….

StockNews.com

New ALS drug funded by Ice Bucket Challenge already in use in South Florida trials

While the country awaits federal approval of a new ALS drug, people in South Florida with the disease already are using it.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

Is the new omicron vaccine worth it?

The omicron-specific booster vaccine hit the market — some wonder if it's worth getting

Salon

Commentary: Did the US jump the gun with the new omicron-targeted vaccines?

Last month, the FDA authorized omicron-specific vaccines, accompanied by breathless science-by-press release and a media blitz. Just days after the FDA’s move, the Centers for Disease Control and Prevention followed, recommending updated boosters for anyone age 12 and up who had received at least two doses of the original COVID-19…

Tribune News Service

Ban drug ads to promote health

Advertising promoting new drugs is effective but often leads to inappropriate prescribing. To protect the health of their citizens, countries should ban it.

360info

A Minnesota man has been sentenced to life in prison for 11 fentanyl deaths

Aaron Broussard was sentenced to life in prison for 11 deaths that were tied to controlled substances he sold. Those who died thought they were taking Adderall, but they actually ingested fentanyl.

WEKU

Read news from The Economist, FT, and more,
with one subscription

Dozen of child deaths prompt Gambia to suspend paracetamol syrup sales

Gambia on Tuesday ordered importers and shops to suspend sales of all brands of paracetamol syrup while the government investigates a suspected link between the medicine and the deaths of dozens of young children.

Reuters

Gene therapy firm growing its Liverpool footprint with new build

A three-storey lab site was approved earlier today

Liverpool Echo

Canadian advocates pledge to continue selling pure drugs amid overdose crisis

Over the last six years, the vast majority of overdose deaths in British Columbia have been driven by impurities in street drugs

The Guardian - US

Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Mersana Therapeutics’ (NASDAQ:MRSN) lead candidate XMT-1660 for the treatment of adult patients with advanced or metastatic triple-negative breast cancer (TNBC). Mersana shares traded as high as 1.79 percent, in a range of $7.48 to $7.94 on day…

Benzinga

2 Biotech Stocks Defying the Bear Market and 1 That's Not

The biotech industry is poised to grow thanks to breakthrough developments and increasing demand from an aging population. Fundamental strength and inelastic demand have been helping biotech stocks Amgen Inc. (AMGN) and Gilead Sciences, Inc. (GILD) defy the bear market. However, Timber Pharmaceuticals, Inc. (TMBR) has been struggling to survive…

StockNews.com

3 Health Care Stock Under $50 You Can Buy Today

The healthcare industry is anticipated to grow significantly in the coming years, thanks to strong demand amid rising chronic diseases, technological advancements, and rising healthcare spending. Therefore, we think fundamentally sound healthcare companies Pfizer (PFE), GSK Plc (GSK), and Teva Pharmaceutical (TEVA), which are currently trading under $50, could be…

StockNews.com

German firm DFE Pharma’s CoE opened in Genome Valley

‘Capabilities offered through this centre can reduce the time to launch a product’

The Hindu

Get all your
news in one place.

100's of premium titles.
One news app.

The National (Scotland)

Cannabis-based medicine approved for use in Scotland for those living with MS

A CANNABIS-BASED medicine has been approved for use for people living with multiple sclerosis (MS) in Scotland.

Asharq Al-Awsat

EU Regulator Backs Pfizer's BA.4/5-Adapted COVID Booster

The European Medicines Agency (EMA) on Monday recommended a COVID-19 booster designed to combat Omicron offshoots BA.4/5, days after endorsing a pair of boosters tailored to target the older BA.1 variant. The latest recommendation is for a so-called bivalent vaccine developed by Pfizer and BioNTech, which targets BA.4/5 as well…

The Independent UK

EU regulator clears Pfizer-BioNTech's tweaked COVID booster

The European Medicines Agency has recommended the authorization of a tweaked booster dose of the Pfizer-BioNTech coronavirus vaccine that includes protection against two of the latest versions of omicron, as countries look to bolster their immunization programs ahead of winter

Pedestrian.tv

Johnson Johnson Will Pay $300M To Women Who’ve Suffered From Pelvic Mesh Implant Complications

The settlement will help cover women's ongoing treatment for injuries caused by the mesh implants.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Biden to announce new support for US biotech production

President Joe Biden is announcing a new initiative to encourage biotech production and research in the U.S. It's the latest move by the White House to boost domestic industry

Benzinga

Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has approved Spectrum Pharmaceuticals’ (NASDAQ:SPPI) lead asset ROLVEDON (eflapegrastim-xnst) injection to decrease the incidence of infection, as manifested by febrile neutropenia. Spectrum Pharmaceuticals shares traded as high as 3.17 percent, in a range of $1.21 to $1.30 on day volume of 6.8 million…

Salon

Juul just lost a big battle

The e-cigarette company was being investigated by more than 30 states for allegedly marketing its products to youth

Los Angeles Times

Michael Hiltzik: This life-saving drug will cost a record $2.8 million. Who will pay the price?

For the estimated 1,500 Americans suffering from a blood disorder known as beta thalassemia, the Food and Drug Administration's approval Aug. 17 of the drug Zynteglo was almost unalloyed good news.

Benzinga

Junshi Biosciences Hits Revenue Roadblock Amid Covid Drug Delay

Key Takeaways: The company logged a revenue fall of 55% in the first half of the year and posted a loss of $131 million Phase 3 clinical trials for its Covid-19 oral drug wrapped up in May but the company has still not yet filed an application to market the…

The Hindu

Zenara launches generic version of Pfizer Covid drug Paxlovid

Sets MRP at ₹5,200 for a box of 20 Nirmatrelvir tablets, 10 tablets of Ritonavir

Bangkok Post

IRPC preparing to buy speciality polymer assets

IRPC, the petrochemical arm of national oil and gas conglomerate PTT Plc, is preparing to buy new assets in the speciality polymer manufacturing segment as it steps up efforts to earn more revenue from high-margin products.

1 … 130 131 132 133

People

Joe Biden

68,029 stories

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

338 stories

Centers for Disease Control and Prevention

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.